中国科技论文统计源期刊　中文核心期刊  
美国《化学文摘》《国际药学文摘》
《乌利希期刊指南》
WHO《西太平洋地区医学索引》来源期刊  
日本科学技术振兴机构数据库（JST）
第七届湖北十大名刊提名奖  

Archive

  • Select all
    |
    药学进展
  • 药学进展
    300 Cases of Hyperlipemia Treated with Taizhian Capsules
    WANG Hanxiang;ZOU Xinrong;HE Chun;SU Guoyang
    2002, 21(9): 292-293.
    Download PDF ( )   Knowledge map   Save
    Objective:To survey the therapeutic effectiveness and adverse reactions of Taizhian capsules in the treatment of hyperlipemia (a morbid state categorized as deficient yin or deficient yin plus excessive yang of the live and kidney, according to the principle of the traditional Chinese medicine known as the overall analysis of the disease as well as the patient). Methods:300 patients with hyperlipemia were given each 3 capsules of Taizhian t.i.d. in a course of 8 consecutive weeks. Results:Taizhian capsules were found to result in an obvious improvement of the patient’s clinical syndrome as assessed by the traditional Chinese medicine. The remedy also brought about a dramatic decrease in serum triglycerides (TG), total cholesterol (TC), lowdensily lipoprotein cholesterol (LDLCh) as well as an increase in serum high density lipoprotein cholesterol (HDLCh). Conclusion:Taizhian capsules have a good therapeutic effect on hyperlipemia, with only mild adverse reactions.
RSS